Archive for September, 2017

Here are the vaccinations you need to get as an adult

Friday, September 1st, 2017:

Before vaccines were developed, infectious diseases such as diphtheria, tetanus and meningitis were the leading cause of death and illness in the world. Vaccines are one of the greatest public health achievements in history, having drastically reduced deaths and illness from infectious causes. There is a large gap between vaccination rates for funded vaccines for adults in Australia and those for infants. More than 93% of infants are vaccinated in Australia, while in adults the rates are between 53-75%. Much more needs to be done to prevent infections in adults, particularly those at risk. If you are an adult in […] Read More →

AMGN’s Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears

Friday, September 1st, 2017:

Today’s Daily Dose brings you news about encouraging preliminary data of Immune Design’s phase II trial of CMB305 in soft tissue sarcoma; Novartis scripting history – with the FDA approval of its CAR-T therapy; FDA approval of Medicines Co.’s VABOMERE and Teva’s AUSTEDO; disappointing results from Otonomy’s phase III clinical trial of OTIVIDEX; the seventh FDA approval Roche’s Actemra and Vivus resolving the pending lawsuit related to its weight-loss drug. Read on… Amgen Inc.’s (AMGN) supplemental New Drug Application to add overall survival results to KYPROLIS’ label has been accepted for review by the FDA – with a decision date […] Read More →

Page 2079 of 2079 1 2 3 2,076 2,077 2,078 2,079
Back to Top